What if there was a drug that cut the risk of breast cancer returning in half, but it came with severe muscle and joint pain? That’s the dilemma facing some women with breast cancer. But a University of Michigan Rogel Cancer Center oncologist says it doesn’t need to be a choice between breast cancer and living in pain.

More than half of all breast cancers are driven by the hormone estrogen, which makes them ideal candidates for treatment with a class of drugs called aromatase inhibitors, or AIs. These are prescribed for post-menopausal women after surgery and are taken for a period of five to 10 years. AIs stop the body from producing estrogen. This approach has proven effective, reducing the chance of breast cancer coming back by about half.

Read the full article here on Michigan Health.